|
Basic InformationMore InformationLatest NewsPreventive Surgeries May Be Lifesaver for Women at High Cancer RiskFood Better Than Supplements for Cancer Prevention: ExpertIn Early Trial, Targeted Therapy Fights Advanced MelanomaRectal Cancer on the Increase in Younger PeopleNicotine Can Fuel Breast Cancer, Study SuggestsVitamin D May Influence Genes for Cancer, Autoimmune DiseaseAlcohol May Raise Risk for Certain Breast CancersInner Workings of Gene Tied to Breast, Ovarian Cancer RevealedVirtual Colonoscopy Can Spot Cancers Outside ColonPalliative Care May Boost Mood, SurvivalCancer Care Differs by Race, Language, and Health StatusNovel Ovarian Cancer Test Shows PromisePatient Role in Cancer Treatment Decisions VariesEstrogen Alone Does Not Increase Lung Cancer RiskMass Spectrometer Test IDs Cancer With High AccuracyDocs Shying Away From Drug That May Prevent Prostate CancerLess May Be More When Treating Early Hodgkin'sRecession Causing Cancer Patients to Quit Life-Extending DrugsGene Variants, High BMI Linked to Prostate Cancer MortalityA New Marker to Spot Aggressive Breast Cancers?Hormone Combination Effective in Metastatic Breast CancerHealth Tip: Screening Early for Colorectal CancerBladder Cancer Linked to Compounds in Processed MeatVaccine Shows Some Promise Against Advanced CancersBreast Cancer's DNA Yields More SecretsVaccine Boosts Survival for Men With Advanced Prostate Cancer: StudyGenetics-Based Risk Score Tied to Risk for Breast CancerMany With Low-Risk Prostate Cancer Get Aggressive TherapyChildhood Cancer May Be Linked to Later Heart ProblemsMultiple Genetic Variants Add to Prostate Cancer RiskFDA Panel Advises Against Bevacizumab for Breast CancerAvastin Largely Safe for Patients With Type of Advanced Lung CancerStudy Suggests Painters Face Increased Risk of Bladder CancerSix-Gene Signature May Predict Pancreatic Cancer PrognosisCigarette Smoke May Up Cancer Risk By Interfering With GenesStudy Suggests Higher Cancer Rate Among IVF BabiesNew Clues to How Cancer Patients' Genes Influence TreatmentTelecare Management Lowers Pain, Depression in CancerExperts Issue New Guidelines on Breast Cancer DrugsPersonal, Substantial Diagnosis Talk Preferred by PatientsStudy Suggests Link Between HPV, Skin CancerFish Oil Usage Linked to Lower Risk of Certain Breast CancersU.S. Cancer Death Rate Keeps Falling: ReportMany Docs Deliver Cancer Diagnosis Badly: StudyCould Hot Weather Affect Results of a Colorectal Cancer Test?CDC: U.S. Colorectal Cancer Screening Rates UpShorter Telomere Length Again Linked to CancerBreast Cancer Gene May Raise Men's Risk, TooBlack Cancer Patients Twice as Likely to Die From DiseasePSA Test Does Cut Prostate Cancer Deaths, Study Finds LinksBook Reviews |
| |
Many With Early Breast Cancer Don't Complete Therapy
by -- Robert Preidt
Updated: Jun 29th 2010
TUESDAY, June 29 (HealthDay News) -- Slightly less than half of early-stage breast cancer patients complete their full prescribed course of hormone therapy, finds a new study.
U.S. researchers examined the automated pharmacy records of 8,769 women diagnosed with stage 1, 2 or 3 hormone-sensitive breast cancer between 1996 and 2007. Each woman filled at least one prescription for hormone therapy within a year of breast cancer diagnosis. The women used tamoxifen (43 percent), aromatase inhibitors (26 percent) or both (30 percent).
Overall, only about 49 percent of the women completed their full prescribed regimen of hormone therapy, the study found. After 4.5 years, 32 percent of the women had stopped taking their hormone therapy. Of those who did not stop, 72 percent finished on schedule (meaning they took their medication more than 80 percent of the time).
Those most likely to discontinue hormone therapy early were found to be women younger than 40. Among these women and women older than 75, those who had a lumpectomy rather than a mastectomy and those who had other medical illnesses were more likely to discontinue the therapy. Those most likely to complete 4.5 years of hormone therapy were Asian/Pacific Islanders, women who'd undergone chemotherapy in the past, those who were married and women who had longer prescription refill intervals.
In general, the researchers said, women stop hormone therapy early for a variety of reasons, including such side effects such as joint pain, hot flashes and fatigue; a lack of understanding about the benefits of the therapy; and the high cost of medications and insurance co-payments.
"Physicians are often unaware of patient compliance, and this is becoming an increasingly important issue in cancer," the study's leader, Dr. Dawn Hershman, an associate professor of medicine and epidemiology at Columbia University Medical Center, said in a news release from the Journal of Clinical Oncology. The study appears online June 28 in the journal.
"It's very disturbing that patients under 40 had the highest discontinuation rates because those patients have the longest life expectancy," Hershman said. "If we can better understand the issues surrounding compliance with hormonal therapy, this might help us understand why patients don't adhere to other treatments that are moving out of the clinic and into the home, such as oral chemotherapy, as often as we would like."
More information
The American Cancer Society has more about hormone therapy for breast cancer.
SOURCE: Journal of Clinical Oncology, June 28, 2010, news release.
This article: Copyright © 2010 HealthDay. All rights reserved. |
